AI assistant
ALGORAE PHARMACEUTICALS LIMITED — Director's Dealing 2009
Sep 28, 2009
64249_rns_2009-09-28_cf705ba9-eabd-4696-ab69-0401f7b9de50.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity LIVING CELL TECHNOLOGIES LTD ABN 14 104 028 042
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | MR DAVID L BROOKES |
|---|---|
| Date of last notice | 30 NOVEMBER 2007 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | DIRECT |
|---|---|
| Nature of indirect interest | |
| (including registered holder) | |
| Note: Provide details of the circumstances giving rise to the relevant | |
| interest. | |
| Date of change | 19 NOVEMBER 2009 |
- See chapter 19 for defined terms.
Appendix 3Y Page 1
11/3/2002
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held prior to change | 100,000 ORDINARY SHARES (HELD BYDAVID LIONEL BROOKES)335,000 ORDINARY SHARES (HELD BYDR DAVID LIONEL BROOKES & MRSELISABETH BROOKES <DR DL BROOKESPERSONAL SUPERFUND A/C>)50,000 ORDINARY SHARES (HELD BYMRSELISABETHMARYBROOKES<DAHLBROOK FAMILY A/C>)150,000 OPTIONS – EXERCISABLE AT$0.20 EACH, VESTING 28/08/2008 ANDEXPIRING 30/11/2012 | 100,000 ORDINARY SHARES (HELD BYDAVID LIONEL BROOKES)335,000 ORDINARY SHARES (HELD BYDR DAVID LIONEL BROOKES & MRSELISABETH BROOKES <DR DL BROOKESPERSONAL SUPERFUND A/C>)50,000 ORDINARY SHARES (HELD BYMRSELISABETHMARYBROOKES<DAHLBROOK FAMILY A/C>)150,000 OPTIONS – EXERCISABLE AT$0.20 EACH, VESTING 28/08/2008 ANDEXPIRING 30/11/2012 | ||
|---|---|---|---|---|
| 250,000 OPTIONS – EXERCISABLE AT$0.30 EACH, VESTING 28/08/2008 ANDEXPIRING 30/11/2012 | ||||
| Class | UNLISTEDOPTIONS(SUJECTTOSHAREHOLDER APPROVAL | |||
| ) | ||||
| Number acquired | 500,000 | |||
| Number disposed | NIL | |||
| Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation | NIL ISSUE PRICE |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
11/3/2002
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held after change | 100,000 ORDINARY SHARES (HELD BYDAVID LIONEL BROOKES)335,000 ORDINARY SHARES (HELD BYDR DAVID LIONEL BROOKES & MRSELISABETH BROOKES <DR DL BROOKESPERSONAL SUPERFUND A/C>)50,000 ORDINARY SHARES (HELD BYMRSELISABETHMARYBROOKES<DAHLBROOK FAMILY A/C>)150,000 OPTIONS – EXERCISABLE AT$0.20 EACH, VESTING 28/08/2008 ANDEXPIRING 30/11/2012250,000 OPTIONS – EXERCISABLE AT$0.30 EACH, VESTING 28/08/2008 ANDEXPIRING 30/11/2012250,000 OPTIONS (HELD BY MRSELISABETH MARY BROOKES<DAHLBROOK FAMILY A/C>) –EXERCISABLE AT $0.25 EACH, VESTING23/8/2010 AND EXPIRING 19/11/2014250,000 OPTIONS (HELD BY MRSELISABETH MARY BROOKES<DAHLBROOK FAMILY A/C>) –EXERCISABLE AT $0.35 EACH, VESTING23/8/2010 AND EXPIRING 19/11/2014 |
|---|---|
| Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back | ISSUEOFOPTIONS(SUBJECTTOSHAREHOLDER APPROVAL AT THE AGMTO BE HELD ON 19/11/2009 |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder(if issued securities) | N/A |
| Date of change | N/A |
| No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relationto which the interest has changed | N/A |
| Interest acquired | N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 3
11/3/2002
Appendix 3Y Change of Director’s Interest Notice
| Interest disposed | N/A |
|---|---|
| Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation | N/A |
| Interest after change | N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 4
11/3/2002